Review of Recent Clinical Developments and Patents for the Treatment of Autoimmune and Inflammatory Diseases by Mesenchymal Stromal Cells

Publisher： Bentham Science Publishers

E-ISSN： 2210-2973|1|3|228-248

ISSN： 2210-2965

Source： Recent Patents on Regenerative Medicine, Vol.1, Iss.3, 2011-09, pp. : 228-248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multipotent Mesenchymal Stromal Cells for Autoimmune Diseases

By  

Transfusion Medicine and Hemotherapy, Vol. 35, Iss. 4, 2008-07 ,pp. : 313-318

Karger

Access to resources Recommend Favorite

Patents Relating to the Application of Autologous Bone Marrow-Derived Mesenchymal Stromal Cell and Whole Marrow Transplantation for Neurodegenerative Diseases: A Review

By  

Recent Patents on Regenerative Medicine, Vol. 2, Iss. 2, 2012-01 ,pp. : 125-136

Bentham Science Publishers

Access to resources Recommend Favorite

Review of Patents and Commercial Opportunities Involving Mesenchymal Stromal Cells (MSCs) Therapies in Osteoarthritis

By  

Recent Patents on Regenerative Medicine, Vol. 4, Iss. 1, 2014-01 ,pp. : 1-15

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells

By  

Transfusion Medicine and Hemotherapy, Vol. 35, Iss. 4, 2008-07 ,pp. : 286-294

Karger

Access to resources Recommend Favorite

The Stromal Activity of Mesenchymal Stromal Cells

By  

Transfusion Medicine and Hemotherapy, Vol. 35, Iss. 3, 2008-05 ,pp. : 185-193

Karger

Access to resources Recommend Favorite